AC
GSK icon

Armistice Capital’s GSK GSK Stock Holding History

Armistice Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-320,000
Closed -$15.4M – 37
2015
Q3 		$15.4M Buy
+320,000
New +$16.7M 5.25% 2

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Armistice Capital's GSK Position: Q2 2026 in Review

Armistice Capital increased its GSK (GSK) stake by 27% in Q2 2026, buying an estimated $3.38M and bringing the position to 300,000 shares worth $15.7M. The position accounts for 0.19% of the portfolio, ranked #74.

Armistice Capital first reported a position in GSK in Q4 2017 and has held it in 15 quarters since. The position peaked at $115M in Q1 2023. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Armistice Capital held 300,000 shares of GSK worth $15.7M as of Q2 2026.
  • Armistice Capital bought 64,000 GSK shares in Q2 2026, an estimated $3.38M.
  • GSK made up 0.19% of Armistice Capital's portfolio in Q2 2026, its #74 holding.
  • Armistice Capital first reported a position in GSK in Q4 2017 and has held it in 15 quarters since.
  • Armistice Capital's GSK position peaked at $115M in Q1 2023.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.